Sialanar is a medicinal solution primarily prescribed for the management of chronic pathological drooling in children and adolescents aged 2 years and older with neurological conditions that lead to excessive saliva production. The active ingredient in Sialanar is glycopyrronium bromide, which belongs to a class of medications known as anticholinergics. These work by blocking the action of acetylcholine, a neurotransmitter in the body that can stimulate saliva production. By doing so, Sialanar effectively reduces the amount of saliva produced, thereby helping to alleviate the symptoms and complications associated with excessive drooling. It is important for this medication to be used under the guidance of a healthcare professional, as it can have specific dosing requirements and potential side effects that need to be monitored.